CH655009A5 - Composizioni utili per la profilassi dell'iperlattacidemia. - Google Patents

Composizioni utili per la profilassi dell'iperlattacidemia. Download PDF

Info

Publication number
CH655009A5
CH655009A5 CH6112/81A CH611281A CH655009A5 CH 655009 A5 CH655009 A5 CH 655009A5 CH 6112/81 A CH6112/81 A CH 6112/81A CH 611281 A CH611281 A CH 611281A CH 655009 A5 CH655009 A5 CH 655009A5
Authority
CH
Switzerland
Prior art keywords
pak
hyperlactacidemia
pyridoxine
administration
ketoglutarate
Prior art date
Application number
CH6112/81A
Other languages
English (en)
Italian (it)
Inventor
Francesco Fici
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of CH655009A5 publication Critical patent/CH655009A5/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH6112/81A 1980-09-22 1981-09-22 Composizioni utili per la profilassi dell'iperlattacidemia. CH655009A5 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24827/80A IT1141070B (it) 1980-09-22 1980-09-22 Impiego dell'alfa-chetoglutarato di piridossina nella profilassi della iperlattacidemia

Publications (1)

Publication Number Publication Date
CH655009A5 true CH655009A5 (it) 1986-03-27

Family

ID=11214855

Family Applications (1)

Application Number Title Priority Date Filing Date
CH6112/81A CH655009A5 (it) 1980-09-22 1981-09-22 Composizioni utili per la profilassi dell'iperlattacidemia.

Country Status (12)

Country Link
US (1) US4361570A (enExample)
JP (1) JPS5782316A (enExample)
BE (1) BE890454A (enExample)
CA (1) CA1177408A (enExample)
CH (1) CH655009A5 (enExample)
DE (1) DE3137125A1 (enExample)
FR (1) FR2490493B1 (enExample)
GB (1) GB2084018A (enExample)
IT (1) IT1141070B (enExample)
NL (1) NL8104357A (enExample)
SE (1) SE459899B (enExample)
ZA (1) ZA816242B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
EP1169322B8 (en) 1999-03-08 2006-09-13 Medicure Inc. Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
AU5840200A (en) * 1999-07-13 2001-01-30 Medicure Inc. Treatment of diabetes and related pathologies
EP1872797A3 (en) 1999-08-24 2008-04-02 Medicure International Inc. Treatment of cardiovascular and related pathologies
EP1268498B1 (en) 2000-02-29 2005-04-13 Medicure International Inc. Cardioprotective phosphonates
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
DE60128912T9 (de) 2000-07-07 2008-06-26 Medicure International Inc. Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
WO2006050598A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
WO2009073944A1 (en) * 2007-12-12 2009-06-18 Iovate T. & P. Inc. USE OF PYRIDOXINE α-HYDROXYISOCAPROATE TO REDUCE METABOLIC ACIDOSIS AND AMMONIA ACCUMULATION
US20090156648A1 (en) * 2007-12-12 2009-06-18 Iovate T. & P. Inc. Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (HICA)
US10278327B2 (en) 2014-05-09 2019-05-07 Shakespeare Company, Llc Trimmer head for use with line and blades
WO2020086733A1 (en) * 2018-10-24 2020-04-30 Ponce De Leon Health Designated Activity Company Nicotinamide riboside compositions for healthspan extension

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6453M (enExample) * 1967-06-13 1968-11-12
ES360566A1 (es) * 1968-11-22 1970-10-16 Made Labor Sa Un metodo de obtencion de alfa-cetoglutarato de piridoxina y sus derivados.
US3784553A (en) * 1972-01-17 1974-01-08 Made Labor Sa Pyridoxine alpha-ketoglutarate and its derivatives

Also Published As

Publication number Publication date
CA1177408A (en) 1984-11-06
FR2490493A1 (fr) 1982-03-26
DE3137125C2 (enExample) 1989-04-06
DE3137125A1 (de) 1982-04-01
US4361570A (en) 1982-11-30
NL8104357A (nl) 1982-04-16
SE8105561L (sv) 1982-03-23
FR2490493B1 (fr) 1986-03-07
IT8024827A0 (it) 1980-09-22
GB2084018A (en) 1982-04-07
BE890454A (fr) 1982-01-18
SE459899B (sv) 1989-08-21
IT1141070B (it) 1986-10-01
ZA816242B (en) 1982-08-25
JPS5782316A (en) 1982-05-22

Similar Documents

Publication Publication Date Title
US4361570A (en) Use of pyridoxine α-ketoglutarate in the prophylaxis of hyperlacticacidaemia
CN110234238B (zh) Nad前体用于改善母体健康和/或后代健康的用途
EP2147671A1 (en) The composition comprising l-carnitine or derivatives thereof and its use
JP2721507B2 (ja) 糖尿病治療剤
EP2116241A1 (en) Pharmaceutical composition
JP3942207B2 (ja) うつ性症状改善剤
JP6420797B2 (ja) 活動意欲向上剤
US20160000716A1 (en) Method of treating vitamin b12 deficiency
JPH07507279A (ja) 経鼻用投与スプレー
JPH07330593A (ja) 疲労改善剤
DE2743704C2 (de) L- oder DL-Phenylglycine enthaltende Arzneimittel
DE69910600T2 (de) Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist
CH649222A5 (it) Composizione farmaceutica per uso terapeutico, per uso diagnostico e quale integratore alimentare.
AU2010295307B2 (en) Phentermine liquid dosage form
Kurlan Dietary therapy for motor fluctuations in Parkinson's disease
US3076747A (en) Pharmaceutical iron preparations
AU761978B2 (en) Use of 2-amino-6- trifluoromehthoxy- benzothiazole for preventing or treating cerebellum dysfunction
Philipps et al. Maturation of early-phase insulin release in the neonatal lamb
EA006776B1 (ru) Фармацевтическая композиция для лечения диабетической невропатии
EP4678174A1 (en) Nizubaglustat for use in the treatment of lysosomal storage disorders
US4219566A (en) Phenylglyoxylic acids and derivatives thereof
US4239779A (en) Use of phenylglyoxylic acids and derivatives thereof in the treatment of ischemic heart disease
US5238960A (en) Use of acetic acid for regulating blood sugar levels
JPS63267716A (ja) 尿素サイクル代謝異常症治療剤
JP3275183B2 (ja) 輸液剤とその製造方法

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased